Lemaitre Vascular (LMAT) Cash from Financing Activities (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Cash from Financing Activities for 17 consecutive years, with -$3.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 38.56% year-over-year to -$3.2 million; the TTM figure through Mar 2026 stood at -$12.5 million (down 108.19% YoY), while the FY2025 annual figure was -$14.5 million, down 109.2% from the prior year.
• Cash from Financing Activities improved to -$3.2 million in Q1 2026 per LMAT's latest filing, from -$3.6 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $164.1 million in Q4 2024 and bottomed at -$5.2 million in Q1 2025.
• Historically, Cash from Financing Activities has averaged $7.3 million across 5 years, with a median of -$2.7 million in 2023.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities soared 6208.75% — and 2025, when it slumped 13533.33%.
• Lemaitre Vascular's Cash from Financing Activities stood at -$2.1 million in 2022, then slipped by 26.58% to -$2.7 million in 2023, then jumped by 6208.75% to $164.1 million in 2024, then slumped by 102.19% to -$3.6 million in 2025, then increased by 10.26% to -$3.2 million in 2026.
• Business Quant data shows LMAT's Cash from Financing Activities at -$3.2 million in Q1 2026, -$3.6 million in Q4 2025, and -$2.9 million in Q3 2025.